Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

Abstract : BACKGROUND: Closed-loop systems that automate insulin delivery may improve glycemic outcomes in patients with type 1 diabetes. METHODS: In this 6-month randomized, multicenter trial, patients with type 1 diabetes were assigned in a 2:1 ratio to receive treatment with a closed-loop system (closed-loop group) or a sensor-augmented pump (control group). The primary outcome was the percentage of time that the blood glucose level was within the target range of 70 to 180 mg per deciliter (3.9 to 10.0 mmol per liter), as measured by continuous glucose monitoring. CONCLUSIONS: In this 6-month trial involving patients with type 1 diabetes, the use of a closed-loop system was associated with a greater percentage of time spent in a target glycemic range than the use of a sensor-augmented insulin pump. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases; iDCL number, NCT03563313.).
Liste complète des métadonnées
Contributeur : Nathalie Salvy-Cordoba <>
Soumis le : lundi 27 avril 2020 - 12:02:18
Dernière modification le : mardi 28 avril 2020 - 01:12:29

Lien texte intégral



Sue Brown, Boris Kovatchev, Dan Raghinaru, John Lum, Bruce Buckingham, et al.. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (18), pp.1707-1717. ⟨10.1056/NEJMoa1907863⟩. ⟨hal-02555438⟩



Consultations de la notice